Literature DB >> 6316720

Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations.

Y Tashiro, Y Watanabe, Y Enomoto.   

Abstract

The effect of a generalized phospholipidosis inducing drug, diethylamino-ethoxyhexestrol (DH, a coronary vasodilator), was studied using rats. The initial alterations are characterized by the appearance of abnormal cytoplasmic inclusion bodies. At the early stage of DH administration, they appeared near the Golgi apparatus. Histochemical and ultrastructural evidence showed that the inclusion bodies consisted of polar lipid, mainly of phospholipids. From cytochemical and biochemical observation, the lysosome was regarded as the primary site of the drug-induced morphological changes. The drug-induced abnormal cytoplasmic inclusion bodies were of three basic morphological types, i.e., multilamellated, crystalloid and finger-print-like bodies. Additionally, many intermediate forms were found showing structural features of those basic types. These drug-induced cytoplasmic changes, namely storage of phospholipids, were considered to be reversible both morphologically and biochemically after the cessation of DH administration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316720

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  3 in total

1.  Pathomorphological changes in rat brain choroid plexus due to administration of the amine-curing agent, bis(4-amino-3-methylcyclohexyl)methane.

Authors:  T Shibata; S Ohshima; Y Shimizu; M Suzuki; M Ishizuka; N Sasaki; E Nakayama
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite.

Authors:  Y Yamanaka; E Sakamoto; Y Sakuma; H Uno; T Koyama; Y Izawa; K Fujiwara
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 3.  Pulmonary and generalized lysosomal storage induced by amphiphilic drugs.

Authors:  Z Hruban
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.